메뉴 건너뛰기




Volumn 50, Issue 24, 2011, Pages 3019-3022

Long-term outcome after multidisciplinary approach for leptomeningeal carcinomatosis in a non-small cell lung cancer patient with poor performance status

Author keywords

Erlotinib; Gefitinib; Leptomeningeal carcinomatosis; Non small cell lung cancer; Ventriculoperitoneal shunting

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; ERLOTINIB; GEFITINIB;

EID: 83755196295     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.50.5903     Document Type: Article
Times cited : (9)

References (13)
  • 2
    • 18544397596 scopus 로고    scopus 로고
    • Comparison of intrathecal chemotherapy for leptomeningeal carcinomatosis of a solid tumor: Methotrexate alone versus methotrexate in combination with cytosine arabinoside and hydrocortisone
    • Kim DY, Lee KW, Yun T, et al. Comparison of intrathecal chemotherapy for leptomeningeal carcinomatosis of a solid tumor: methotrexate alone versus methotrexate in combination with cytosine arabinoside and hydrocortisone. Jpn J Clin Oncol 33: 608-612, 2003.
    • (2003) Jpn J Clin Oncol , vol.33 , pp. 608-612
    • Kim, D.Y.1    Lee, K.W.2    Yun, T.3
  • 3
    • 22044445517 scopus 로고    scopus 로고
    • Erlotinib in previously treated non-small-cell lung cancer
    • Shepherd FA, Rodrigues Pereira J, Ciuleanu T, et al. Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med 353: 123-132, 2005.
    • (2005) N Engl J Med , vol.353 , pp. 123-132
    • Shepherd, F.A.1    Rodrigues Pereira, J.2    Ciuleanu, T.3
  • 4
    • 59649105302 scopus 로고    scopus 로고
    • EGFR-TKI and lung adenocarcinoma with CNS relapse: Interest of molecular follow-up
    • Ruppert AM, Beau-Faller M, Neuville A, et al. EGFR-TKI and lung adenocarcinoma with CNS relapse: interest of molecular follow-up. Eur Respir J 33: 436-440, 2009.
    • (2009) Eur Respir J , vol.33 , pp. 436-440
    • Ruppert, A.M.1    Beau-Faller, M.2    Neuville, A.3
  • 5
    • 18844417090 scopus 로고    scopus 로고
    • High incidence of disease recurrence in the brain and leptomeninges in patients with nonsmall cell lung carcinoma after response to gefitinib
    • Omuro AM, Kris MG, Miller VA, et al. High incidence of disease recurrence in the brain and leptomeninges in patients with nonsmall cell lung carcinoma after response to gefitinib. Cancer 103: 2344-2348, 2005.
    • (2005) Cancer , vol.103 , pp. 2344-2348
    • Omuro, A.M.1    Kris, M.G.2    Miller, V.A.3
  • 6
    • 30944434263 scopus 로고    scopus 로고
    • Gefitinib response of erlotinib-refractory lung cancer involving meninges--role of EGFR mutation
    • Choong NW, Dietrich S, Seiwert TY, et al. Gefitinib response of erlotinib-refractory lung cancer involving meninges--role of EGFR mutation. Nat Clin Pract Oncol 3: 50-57, 2006.
    • (2006) Nat Clin Pract Oncol , vol.3 , pp. 50-57
    • Choong, N.W.1    Dietrich, S.2    Seiwert, T.Y.3
  • 7
    • 70449584901 scopus 로고    scopus 로고
    • Efficacy of erlotinib for brain and leptomeningeal metastases in patients with lung adenocarcinoma who showed initial good response to gefitinib
    • Katayama T, Shimizu J, Suda K, et al. Efficacy of erlotinib for brain and leptomeningeal metastases in patients with lung adenocarcinoma who showed initial good response to gefitinib. J Thorac Oncol 4: 1415-1419, 2009.
    • (2009) J Thorac Oncol , vol.4 , pp. 1415-1419
    • Katayama, T.1    Shimizu, J.2    Suda, K.3
  • 8
    • 83755230500 scopus 로고    scopus 로고
    • TNM Classification of Malignant Tumors. Sobin LH, Wittekind C, Eds. Wiley and Sons, New York
    • TNM Classification of Malignant Tumors. Sobin LH, Wittekind C, Eds. Wiley and Sons, New York, 2002: 97-103.
    • (2002) , pp. 97-103
  • 9
    • 33749046899 scopus 로고    scopus 로고
    • Response and resistance in a non-small-cell lung cancer patient with an epidermal growth factor receptor mutation and leptomeningeal metastases treated with high-dose gefitinib
    • Jackman DM, Holmes AJ, Lindeman N, et al. Response and resistance in a non-small-cell lung cancer patient with an epidermal growth factor receptor mutation and leptomeningeal metastases treated with high-dose gefitinib. J Clin Oncol 24: 4517-4520, 2006.
    • (2006) J Clin Oncol , vol.24 , pp. 4517-4520
    • Jackman, D.M.1    Holmes, A.J.2    Lindeman, N.3
  • 10
    • 67349186396 scopus 로고    scopus 로고
    • Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are effective for leptomeningeal metastasis from non-small cell lung cancer patients with sensitive EGFR mutation or other predictive factors of good response for EGFR TKI
    • Yi HG, Kim HJ, Kim YJ, et al. Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are effective for leptomeningeal metastasis from non-small cell lung cancer patients with sensitive EGFR mutation or other predictive factors of good response for EGFR TKI. Lung Cancer 65: 80-84, 2009.
    • (2009) Lung Cancer , vol.65 , pp. 80-84
    • Yi, H.G.1    Kim, H.J.2    Kim, Y.J.3
  • 11
    • 0012381722 scopus 로고    scopus 로고
    • Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected]
    • Fukuoka M, Yano S, Giaccone G, et al. Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected]. J Clin Oncol 21: 2237-2246, 2003.
    • (2003) J Clin Oncol , vol.21 , pp. 2237-2246
    • Fukuoka, M.1    Yano, S.2    Giaccone, G.3
  • 12
    • 0142055937 scopus 로고    scopus 로고
    • Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: A randomized trial
    • Kris MG, Natale RB, Herbst RS, et al. Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial. JAMA 290: 2149-2158, 2003.
    • (2003) JAMA , vol.290 , pp. 2149-2158
    • Kris, M.G.1    Natale, R.B.2    Herbst, R.S.3
  • 13
    • 18144400958 scopus 로고    scopus 로고
    • Ventriculoperitoneal shunt in patients with leptomeningeal metastasis
    • Omuro AM, Lallana EC, Bilsky MH, DeAngelis LM. Ventriculoperitoneal shunt in patients with leptomeningeal metastasis. Neurology 64: 1625-1627, 2005.
    • (2005) Neurology , vol.64 , pp. 1625-1627
    • Omuro, A.M.1    Lallana, E.C.2    Bilsky, M.H.3    Deangelis, L.M.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.